News
GNTA
2.170
-0.46%
-0.010
Weekly Report: what happened at GNTA last week (1103-1107)?
Weekly Report · 4d ago
Genenta Science Expands Board and Corporate Purpose Following Shareholders’ Meeting
TipRanks · 11/04 11:33
Weekly Report: what happened at GNTA last week (1027-1031)?
Weekly Report · 11/03 10:39
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 10/29 17:06
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 10/29 12:06
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/29 09:05
GNTA, BBIO, AMRN Jump After Hours: Key Biotech Catalysts Driving Stock Gains
NASDAQ · 10/29 05:03
Genenta Science Secures $15 Million in Registered Direct Offering
TipRanks · 10/28 10:46
Genenta: Lentiviral Vector Technology Early Survival GBM Signal Warrants Buy Rating
Seeking Alpha · 10/27 21:31
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 10/27 17:05
Gold Falls 3%; Carter's Shares Gain After Q3 Earnings
Benzinga · 10/27 17:03
Nasdaq Surges 300 Points; Keurig Dr Pepper Shares Jump After Q3 Results
Benzinga · 10/27 13:56
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 10/27 12:06
Genenta Science Shares Drop Premarket After Stock Offering Prices
Dow Jones · 10/27 12:04
Weekly Report: what happened at GNTA last week (1020-1024)?
Weekly Report · 10/27 10:44
Genenta Science Appoints New Board Member and Confirms CEO
TipRanks · 10/27 10:28
Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/27 08:53
Biggest stock movers Monday: RNA, HIVE, and more
Seeking Alpha · 10/27 08:30
Genenta Science jumps on $15M direct offering
Seeking Alpha · 10/27 07:20
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
Barchart · 10/26 19:30
More
Webull provides a variety of real-time GNTA stock news. You can receive the latest news about Genenta Science Spa through multiple platforms. This information may help you make smarter investment decisions.
About GNTA
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.